Back

A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint versus Prespecified Ablation Strategy Followed by Cardioversion in Patients with Persistent

31 August 2026 (09:15 - 09:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: optimising atrial fibrillation ablation Catheter Ablation of Arrhythmias ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ziliang Song

Shanghai Chest Hospital, Shanghai (China)

5 More presentations in this session

Presentation thumbnail
Improving esophageal protection during AF ablation: a multicenter randomized controlled trial
Doctor V. Sagar (Greater London, GB)
Slides Video
Presentation thumbnail
Left atrial posterior isolation in addition to pulmonary vein isolation in patients with persistent AF refractory to pharmacologic cardioversion: The LEAP-AF randomized clinical trial
Doctor K. Okawa (Takamatsu, JP)
Slides Video
Presentation thumbnail
Additional Low-Voltage-Area ablation During Atrial Fibrillation Rhythm In Patients With Persistent Atrial Fibrillation: a prospective, randomized clinical trial
Mrs H. Chu (Yantai, CN)
Slides
Presentation thumbnail
A Randomised Controlled Trial of Ripple Mapping-guided isthmus ablation versus Local Activation Time-guided ablation in Atrial Tachycardia: The Ripple AT-plus study
Doctor B. Kailey (London, GB)
Slides
Presentation thumbnail
The FLEX-PVI Trial: High-Power Short-Duration Pulmonary Vein Isolation Using a Flexible-Tip Contact Force-Sensing Catheter
Doctor K. Kuroki (Chuo, JP)
Slides

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: optimising atrial fibrillation ablation
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Acute termination as an endpoint in individualised electrophysiological substrate ablation in persistent atrial fibrillation
27 August 2023
thumbnail
Congress Session
Late-Breaking Science: atrial fibrillation ablation
31 March 2025
thumbnail
Congress Presentation
One-year follow-up of patients with persistent atrial fibrillation after Farapulse ablation - comparison of two ablation strategies
12 April 2026
thumbnail
Congress Session
Epicardial/endocardial hybrid treatments: combining strengths, restoring rhythm
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources